ArticleCancer medicine2023

Analysis on the risk of myasthenia gravis related to immune checkpoint inhibitors based on the US FDA Adverse Event Reporting System.

Qingli Kong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.